Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells (Q44998014)

8 December 2017

title

Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells (English)

1 reference

8 December 2017

S Geyh

1

1 reference

8 December 2017

S Oz

2

1 reference

8 December 2017

R-P Cadeddu

3

1 reference

8 December 2017

J Fröbel

4

1 reference

8 December 2017

B Brückner

5

1 reference

8 December 2017

A Kündgen

6

1 reference

8 December 2017

R Fenk

7

1 reference

8 December 2017

I Bruns

8

1 reference

8 December 2017

C Zilkens

9

1 reference

8 December 2017

D Hermsen

10

1 reference

8 December 2017

N Gattermann

11

1 reference

8 December 2017

G Kobbe

12

1 reference

8 December 2017

U Germing

13

1 reference

8 December 2017

F Lyko

14

1 reference

8 December 2017

R Haas

15

1 reference

8 December 2017

T Schroeder

16

1 reference

8 December 2017

publication date

29 March 2013

1 reference

8 December 2017

1 reference

8 December 2017

volume

27

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

1841-1851

1 reference

Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Persistent malignant stem cells in del(5q) myelodysplasia in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Contribution of bone microenvironment to leukemogenesis and leukemia progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Bone and the hematopoietic niche: a tale of two stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Effects of high-dose chemotherapy on bone marrow multipotent mesenchymal stromal cells isolated from lymphoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Aging and chronic sun exposure cause distinct epigenetic changes in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Genome-wide promoter DNA methylation dynamics of human hematopoietic progenitor cells during differentiation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Functions of DNA methylation: islands, start sites, gene bodies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Gene body-specific methylation on the active X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Stem Cell Interactions in a Bone Marrow Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Tracking of replicative senescence in mesenchymal stem cells by colony-forming unit frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

The T-box transcription factor Tbx15 is required for skeletal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Role of c-Kit and erythropoietin receptor in erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

Chromosomal abnormalities in marrow stromal cells from myelodysplastic syndromes (MDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Focal adhesion protein abnormalities in myelodysplastic mesenchymal stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Bone remodeling alterations in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.193

7 January 2021

Identifiers

DOI

10.1038/LEU.2013.193

1 reference

8 December 2017

1 reference